These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6831827)

  • 1. Verapamil plasma binding: relationship to alpha 1-acid glycoprotein and drug efficacy.
    McGowan FX; Reiter MJ; Pritchett EL; Shand DG
    Clin Pharmacol Ther; 1983 Apr; 33(4):485-90. PubMed ID: 6831827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lidocaine plasma protein binding.
    Routledge PA; Barchowsky A; Bjornsson TD; Kitchell BB; Shand DG
    Clin Pharmacol Ther; 1980 Mar; 27(3):347-51. PubMed ID: 7357791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum.
    Belpaire FM; Wynant P; Van Trappen P; Dhont M; Verstraete A; Bogaert MG
    Br J Clin Pharmacol; 1995 Feb; 39(2):190-3. PubMed ID: 7742161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha 1-Acid glycoprotein and plasma lidocaine binding.
    Shand DG
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():27-31. PubMed ID: 6705424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between alpha 1-acid glycoprotein and lidocaine disposition in myocardial infarction.
    Routledge PA; Shand DG; Barchowsky A; Wagner G; Stargel WW
    Clin Pharmacol Ther; 1981 Aug; 30(2):154-7. PubMed ID: 7249498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance by verapamil and modulation by alpha 1-acid glycoprotein in wild-type and multidrug-resistant Chinese hamster ovary cell lines.
    Chatterjee M; Robson CN; Harris AL
    Cancer Res; 1990 May; 50(9):2818-22. PubMed ID: 1970277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding.
    Abramson FP; Jenkins J; Ostchega Y
    Clin Pharmacol Ther; 1982 Nov; 32(5):659-63. PubMed ID: 7128007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.
    Sager G; Jaeger R; Little C
    Br J Clin Pharmacol; 1989 Feb; 27(2):229-34. PubMed ID: 2713217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.
    Paxton JW; Briant RH
    Br J Clin Pharmacol; 1984 Nov; 18(5):806-10. PubMed ID: 6508990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide.
    Bredesen JE; Kierulf P
    Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective binding of propranolol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein.
    Hanada K; Ohta T; Hirai M; Arai M; Ogata H
    J Pharm Sci; 2000 Jun; 89(6):751-7. PubMed ID: 10824133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha1-acid glycoprotein concentration and protein binding in trauma.
    Edwards DJ; Lalka D; Cerra F; Slaughter RL
    Clin Pharmacol Ther; 1982 Jan; 31(1):62-7. PubMed ID: 7053306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1-acid glycoprotein concentrations and protein binding of propranolol in Sprague-Dawley and Dark Agouti rat strains treated by phenobarbital.
    Chauvelot-Moachon L; Delers F; Poüs C; Engler R; Tallet F; Giroud JP
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1103-8. PubMed ID: 3252025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipramine binding to alpha-1-acid glycoprotein in normal subjects and cardiac patients.
    Freilich DI; Giardina EG
    Clin Pharmacol Ther; 1984 May; 35(5):670-4. PubMed ID: 6713778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of endotoxin on the stereoselective pharmacokinetics of oxprenolol, propranolol, and verapamil in the rat.
    Laethem ME; Belpaire FM; Wijnant P; Rosseel MT; Bogaert MG
    Chirality; 1994; 6(5):405-10. PubMed ID: 8068500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of d-methadone, l-methadone, and dl-methadone to proteins in plasma of healthy volunteers: role of the variants of alpha 1-acid glycoprotein.
    Eap CB; Cuendet C; Baumann P
    Clin Pharmacol Ther; 1990 Mar; 47(3):338-46. PubMed ID: 2311335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the sialylation state of alpha 1-acid glycoprotein on propranolol binding.
    Primozic S; McNamara PJ
    J Pharm Sci; 1985 Apr; 74(4):473-5. PubMed ID: 3999012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs.
    Goolkasian DL; Slaughter RL; Edwards DJ; Lalka D
    Eur J Clin Pharmacol; 1983; 25(3):413-7. PubMed ID: 6628530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.